Related Experiment Video
Updated: Aug 15, 2025

09:17
Quantitative Static and Dynamic Assessment of Balance Control in Stroke Patients
Published on: May 17, 2020
3.4K
A 3-minute recumbent stepper test in chronic stroke.
Daniel L Carl1, Dustyn Whitesel1, Colleen Meyrose1
1Department of Rehabilitation, Exercise, and Nutrition Sciences, University of Cincinnati, Cincinnati, Ohio, USA.
PM & R : the Journal of Injury, Function, and Rehabilitation
|December 29, 2022
Summary
A new Recumbent Stepper 3-minute (RS 3Min) "all out" test improves cardiovascular screening sensitivity in stroke survivors. This test helps achieve target heart rates more effectively than traditional graded exercise tests.
Area of Science:
- Cardiovascular disease
- Neurology
- Exercise physiology
Background:
- Stroke survivors often struggle to reach target heart rates during graded exercise testing (GXT).
- This limitation can reduce the sensitivity of GXT for detecting cardiac conditions in this population.
- A novel Recumbent Stepper 3-minute (RS 3Min) "all out" test is proposed to enhance stress testing sensitivity post-stroke.
Purpose of the Study:
- To assess the feasibility of incorporating the RS 3Min test following a standard GXT in individuals who have experienced a stroke.
- To determine if the RS 3Min test can improve the ability of stroke survivors to reach their target heart rate during exercise testing.
Main Methods:
- A within-participant, repeated measures design was employed.
- Fifteen participants with chronic stroke underwent two testing protocols: a symptom-limited treadmill GXT and a symptom-limited Recumbent Stepper GXT followed by the RS 3Min critical power test.
- Key measures included heart rate, perceived exertion, oxygen consumption, respiratory exchange ratio, power output, and blood pressure.
Main Results:
- The RS 3Min test demonstrated a significantly higher rate of achieving target heart rate compared to the RS GXT (9/14 vs. 4/14, p=0.02).
- The RS 3Min test showed comparable results to the treadmill GXT regarding target heart rate achievement (9/14 vs. 5/14, p=0.09).
- Minimum power output during the RS 3Min test was significantly higher than peak power output during the RS GXT (110±41 W vs. 84±22 W, p=0.02), with 12/15 participants reaching a VO2 plateau.
Conclusions:
- The novel RS 3Min "all out" test shows promise for improving cardiovascular screening sensitivity in stroke survivors.
- This test may offer a valid method for assessing critical power in this population.
- Further research with randomized designs is recommended to confirm these findings.

